acetylcysteine has been researched along with Shock, Septic in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (31.03) | 18.2507 |
| 2000's | 18 (62.07) | 29.6817 |
| 2010's | 2 (6.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckley, M; Krakauer, T | 1 |
| Batteux, F; Benhamou, D; Borderie, D; Cherreau, C; Conti, M; Dupic, L; Duranteau, J; Huet, O; Mira, JP; Nicco, C; Pene, F; Vicaut, E | 1 |
| Ellouze, O; Frikha, N; Mestiri, T; Ouerghi, S; Salah Ben Ammar, M | 1 |
| Lenschat, A; Morrison, DC; Perera, PY; Qureshi, N; Shen, J; Splitter, G; Vogel, SN; Zhang, G | 1 |
| Del Sorbo, L; Zhang, H | 1 |
| Armstrong, VW; Hein, OV; Kox, WJ; Oellerich, M; Ohring, R; Schilling, A; Spies, C | 1 |
| Asfar, P; De Backer, D; Meier-Hellmann, A; Radermacher, P; Sakka, SG | 1 |
| Spapen, H | 1 |
| Huang, XL; Ling, YL; Ling, YQ; Zhang, JL; Zhu, TN | 1 |
| Kolbert, C; Morrison, DC; Papasian, C; Qureshi, AA; Qureshi, N; Raghavakaimal, S; Reis, J; Shen, J; Vogel, SN | 1 |
| Chen, HI; Harn, HJ; Hsu, BG; Lee, RP; Yang, FL | 1 |
| Banks, S; Costello, R; Csako, G; Danner, RL; Eichacker, P; Esposito, C; Kalil, AC; Myers, DE; Natanson, C; Sevransky, JE; Sittler, KJ; Solomon, SB; Susla, GM; Vandivier, RW | 1 |
| Bakker, J; Nguyen, DN; Rogiers, P; Spapen, H; Vincent, JL; Zhang, H | 1 |
| Bakker, J; Depierreux, M; van Asbeck, S; Vincent, JL; Zhang, H | 1 |
| Bredle, DL; Hannemann, L; Meier-Hellmann, A; Reinhart, K; Schaffartzik, W; Spies, CD; Witt, I | 1 |
| Leppard, PI; Moran, JL; Peake, SL | 1 |
| Galley, HF; Howdle, PD; Walker, BE; Webster, NR | 1 |
| Demanet, C; Huyghens, L; Spapen, H; Vincent, JL; Vleminckx, W; Zhang, H | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S; Mazzon, E | 1 |
| De la Fuente, M; Del Río, M; Garrote, D; Guayerbas, N; Víctor, VM | 1 |
| De la Fuente, M; Victor, VM | 2 |
| Fan, J; Kapus, A; Li, YH; Marshall, JC; Rizoli, S; Rotstein, OD | 1 |
| Cantini, Q; Conti, A; De Gaudio, AR; Moraldi, E; Novelli, G; Ortolani, O | 1 |
| Haertel, C; Lenhart, A; Meier-Hellmann, A; Michel, C; Rank, N; Spies, C; Welte, M | 1 |
| Kiefer, P; Radermacher, P; Vogt, J | 1 |
| Breitkreutz, R; Groth, G; Heller, AR; Heller, SC; Koch, T; Nebe, T; Quintel, M | 1 |
| Ahola, T; Lapatto, R | 1 |
| Conti, A; De Gaudio, AR; Moraldi, E; Novelli, GP; Ortolani, O | 1 |
4 review(s) available for acetylcysteine and Shock, Septic
| Article | Year |
|---|---|
[N-acetylcysteine in septic shock].
Topics: Acetylcysteine; Free Radical Scavengers; Humans; Shock, Septic | 2011 |
Clinical review: influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock.
Topics: Acetylcysteine; Fluid Therapy; Hemodynamics; Humans; Intestinal Mucosa; Liver; Multiple Organ Failure; Oxygen; Respiration, Artificial; Shock, Septic; Splanchnic Circulation; Vasoconstrictor Agents | 2004 |
From mucolytic to antioxidant and liver protection: new aspects in the intensive care unit career of N-acetylcysteine.
Topics: Acetylcysteine; Antioxidants; Critical Care; Expectorants; Humans; Liver Circulation; Shock, Septic | 2000 |
[N-Acetylcysteine: new possibilities to use an old substance].
Topics: Acetaminophen; Acetylcysteine; Antioxidants; Free Radical Scavengers; Glutathione; Humans; Liver Failure; Oxidative Stress; Randomized Controlled Trials as Topic; Shock, Septic | 1999 |
7 trial(s) available for acetylcysteine and Shock, Septic
| Article | Year |
|---|---|
Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
Topics: Acetylcysteine; Adult; Combined Modality Therapy; Double-Blind Method; Female; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Physiologic; Oxygen Consumption; Prospective Studies; Shock, Septic; Statistics, Nonparametric; Survival Rate | 1994 |
N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock.
Topics: Acetylcysteine; Aged; APACHE; Catecholamines; Double-Blind Method; Female; Heart; Hemodynamics; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Shock, Septic | 1996 |
The effects of intravenous antioxidants in patients with septic shock.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; Drug Therapy, Combination; Free Radicals; Hemodynamics; Humans; Injections, Intravenous; Lipid Peroxides; Male; Middle Aged; Nitrites; Oxidation-Reduction; Shock, Septic; Vitamin E | 1997 |
Does N-acetyl-L-cysteine influence cytokine response during early human septic shock?
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Antigens, CD; Double-Blind Method; Female; Hemodynamics; Humans; Infusions, Intravenous; Interleukin-10; Interleukin-6; Interleukin-8; Interleukins; Lactic Acid; Lung Compliance; Male; Middle Aged; Oxygen Consumption; Prospective Studies; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Shock, Septic; Tumor Necrosis Factor-alpha | 1998 |
The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock.
Topics: Acetylcysteine; Adult; Aged; Antioxidants; APACHE; Critical Care; Female; Glutathione; Humans; Infusions, Intravenous; Lipid Peroxidation; Male; Middle Aged; Shock, Septic; Survival Rate; Treatment Outcome | 2000 |
N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study.
Topics: Acetylcysteine; Adult; Aged; Blood Flow Velocity; Coloring Agents; Double-Blind Method; Female; Free Radical Scavengers; Hemodynamics; Humans; Indocyanine Green; Infusions, Intravenous; Injections, Intravenous; Lidocaine; Liver; Liver Circulation; Liver Function Tests; Male; Metabolic Clearance Rate; Microsomes, Liver; Middle Aged; Oxygen Consumption; Prospective Studies; Shock, Septic; Survival Analysis | 2000 |
N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients.
Topics: Acetylcysteine; Adult; Analysis of Variance; APACHE; Female; Flow Cytometry; Free Radical Scavengers; Hospital Mortality; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Neutrophils; Phagocytosis; Prospective Studies; Respiratory Burst; Shock, Septic; Survival Analysis; Time Factors | 2001 |
18 other study(ies) available for acetylcysteine and Shock, Septic
| Article | Year |
|---|---|
Efficacy of two FDA-approved drug combination in a mouse model of staphylococcal enterotoxin B-induced shock.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Chemokine CCL2; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Enterotoxins; Female; Free Radical Scavengers; Interferon-gamma; Interleukin-2; Interleukin-6; Lung; Male; Mice; Shock, Septic | 2013 |
Pivotal role of glutathione depletion in plasma-induced endothelial oxidative stress during sepsis.
Topics: Acetylcysteine; Adult; Aged; APACHE; Cell Death; Endothelium, Vascular; Female; Free Radical Scavengers; Glutathione; Humans; Intensive Care Units; Male; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Shock, Septic | 2008 |
The proteasome as a lipopolysaccharide-binding protein in macrophages: differential effects of proteasome inhibition on lipopolysaccharide-induced signaling events.
Topics: Acetylcysteine; Acute-Phase Proteins; Animals; Carrier Proteins; Cell Line; Chymotrypsin; Cross-Linking Reagents; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Down-Regulation; Enzyme Activation; Escherichia coli; Glutamate Synthase; Leupeptins; Lipopolysaccharides; Macrophages; Macrophages, Peritoneal; Membrane Glycoproteins; Membrane Proteins; Methanosarcina; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Multienzyme Complexes; Phosphorylation; Proteasome Endopeptidase Complex; Shock, Septic; Signal Transduction; Tritium | 2003 |
Is there a place for N-acetylcysteine in the treatment of septic shock?
Topics: Acetylcysteine; Antioxidants; Hemodynamics; Humans; Lidocaine; Liver; Liver Circulation; Shock, Septic | 2004 |
N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report.
Topics: Acetylcysteine; Adult; Aged; Antioxidants; Female; Hemodynamics; Humans; Lactates; Lidocaine; Liver; Liver Circulation; Liver Function Tests; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oxygen Consumption; Prospective Studies; Shock, Septic; Signal Transduction; Survival Analysis; Vasoconstriction | 2004 |
N-acetylcysteine in clinical sepsis: a difficult marriage.
Topics: Acetylcysteine; Cytokines; Gastric Mucosa; Humans; Intensive Care Units; Oxidative Stress; Oxygen Consumption; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic | 2004 |
Multiple factors contributing to lipopolysaccharide-induced reactivity changes in rabbit pulmonary artery.
Topics: Acetylcysteine; Animals; Carbon Monoxide; Hypertension, Pulmonary; Lipopolysaccharides; Male; Nitric Oxide; Pulmonary Artery; Rabbits; Shock, Septic | 2005 |
Key inflammatory signaling pathways are regulated by the proteasome.
Topics: Acetylcysteine; Animals; Cell Survival; Chymotrypsin; Gene Expression Regulation, Enzymologic; Inflammation; Lipopolysaccharides; Macrophages; Mice; Oligonucleotide Array Sequence Analysis; Proteasome Endopeptidase Complex; Shock, Septic; Signal Transduction; Toll-Like Receptor 4 | 2006 |
Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats.
Topics: Acetylcysteine; Animals; Blood Pressure; Cytokines; Drug Administration Schedule; Free Radical Scavengers; Heart; Heart Rate; Kidney; Kidney Function Tests; Lipopolysaccharides; Liver; Liver Function Tests; Male; Multiple Organ Failure; Myocardium; Rats; Rats, Inbred WKY; Shock, Septic | 2006 |
Preclinical trial of L-arginine monotherapy alone or with N-acetylcysteine in septic shock.
Topics: Acetylcysteine; Animals; Arginine; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Free Radical Scavengers; Immunotherapy; Nitric Oxide; Parenteral Nutrition; Proportional Hazards Models; Random Allocation; Shock, Septic; Survival Analysis | 2006 |
Effects of N-acetyl-L-cysteine on regional blood flow during endotoxic shock.
Topics: Acetylcysteine; Animals; Dogs; Femoral Artery; Free Radical Scavengers; Hemodynamics; Mesenteric Arteries; Oxygen; Regional Blood Flow; Renal Artery; Shock, Septic | 1995 |
Effects of N-acetylcysteine in endotoxic shock.
Topics: Acetylcysteine; Analysis of Variance; Animals; Blood Pressure; Cardiac Output; Disease Models, Animal; Dogs; Lactates; Random Allocation; Respiratory Function Tests; Shock, Septic; Tumor Necrosis Factor-alpha; Vasodilator Agents | 1994 |
Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat.
Topics: Acetylcysteine; Animals; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Free Radical Scavengers; Leukocyte Count; Male; Multiple Organ Failure; Nitrates; Nitric Oxide; Peritonitis; Random Allocation; Rats; Rats, Sprague-Dawley; Shock, Septic; Survival Analysis; Time Factors; Zymosan | 1999 |
Modulation of murine macrophage function by N-acetylcysteine in a model of endotoxic shock.
Topics: Acetylcysteine; Animals; Cell Adhesion; Chemotaxis; Disease Models, Animal; Escherichia coli; Female; In Vitro Techniques; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; N-Formylmethionine Leucyl-Phenylalanine; Phagocytosis; Shock, Septic; Superoxides; Tumor Necrosis Factor-alpha | 1999 |
Anti-oxidants as modulators of immune function.
Topics: Acetylcysteine; Adjuvants, Immunologic; Adult; Aged; Aging; Animals; Antioxidants; Cell Adhesion; Disease Models, Animal; Female; Humans; In Vitro Techniques; Lymphocyte Activation; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Shock, Septic; Vitamin E | 2000 |
Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor.
Topics: Acetylcysteine; Animals; Antioxidants; Blood Coagulation Disorders; Bronchoalveolar Lavage Fluid; Capillary Leak Syndrome; Disseminated Intravascular Coagulation; Fibrin; Fibrinolysis; Gene Expression Regulation; Lipopolysaccharides; Lipoproteins; Macrophage Activation; Macrophages, Alveolar; Male; Models, Biological; Neutrophils; NF-kappa B; Oxidative Stress; Plasminogen Activator Inhibitor 1; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Respiratory Distress Syndrome; Shock, Hemorrhagic; Shock, Septic; Thromboplastin; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2000 |
Ascorbic acid and N-acetylcysteine improve in vitro the function of lymphocytes from mice with endotoxin-induced oxidative stress.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Cell Adhesion; Cells, Cultured; Chemotaxis; Escherichia coli; Female; In Vitro Techniques; Lipopolysaccharides; Lymphocytes; Mice; Mice, Inbred BALB C; Oxidative Stress; Phagocytosis; Reactive Oxygen Species; Shock, Septic; Tumor Necrosis Factor-alpha | 2001 |
[Glutathione and N-acetylcysteine in the prevention of free-radical damage in the initial phase of septic shock].
Topics: Acetylcysteine; Free Radical Scavengers; Free Radicals; Glutathione; Humans; Shock, Septic | 2002 |